blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2027851

EP2027851 - Topical pharmaceutical formulations and methods of treatment [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.09.2010
Database last updated on 26.06.2024
Most recent event   Tooltip17.09.2010Application deemed to be withdrawnpublished on 20.10.2010  [2010/42]
Applicant(s)For all designated states
PharmaKodex Limited
1 Prospect West Chippenham
Wiltshire SN14 6FH / GB
[2009/50]
Former [2009/09]For all designated states
Vectura Limited
1 Prospect West
Chippenham, Wiltshire SN14 6FH / GB
Inventor(s)01 / Staniforth, John Nicholas
c/o Ventura Limited 1 Prospect West
SN14 6FH Wiltshire Chippenham / GB
02 / Tobyn, Michael John
c/o Ventura Limited 1 Prospect West
SN14 6FH Wiltshire Chippenham / GB
 [2009/09]
Representative(s)McNeeney, Stephen Phillip
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2010/01]McNeeney, Stephen Phillip
Potter Clarkson LLP Park View House 58 The Ropewalk
Nottingham NG1 5DD / GB
Former [2009/09]Teuten, Andrew John, et al
Sagittarius Intellectual Property Consultants Ltd Taylor House 39 High Street
Marlow, Bucks. SL7 1AF / GB
Application number, filing date07122565.026.06.2001
[2009/09]
Priority number, dateGB2000001561726.06.2000         Original published format: GB 0015617
[2009/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2027851
Date:25.02.2009
Language:EN
[2009/09]
Search report(s)(Supplementary) European search report - dispatched on:EP21.01.2009
ClassificationIPC:A61K9/20, A61K9/16
[2009/09]
CPC:
A61K9/2013 (EP,US); A61K9/20 (KR); A61P17/00 (EP);
A61P17/06 (EP); A61P25/04 (EP); A61P25/20 (EP);
A61P29/00 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61P9/00 (EP); A61P9/08 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2009/09]
TitleGerman:Topische pharmazeutische Formulierungen und Behandlungsverfahren[2009/09]
English:Topical pharmaceutical formulations and methods of treatment[2009/09]
French:Formulations pharmaceutiques topiques et procédés de traitement[2009/09]
Examination procedure17.04.2008Loss of particular rights, legal effect: Claims
05.06.2008Despatch of communication of loss of particular rights: Claims {1}
14.08.2009Examination requested  [2009/39]
23.10.2009Despatch of a communication from the examining division (Time limit: M04)
13.03.2010Application deemed to be withdrawn, date of legal effect  [2010/42]
04.05.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/42]
Parent application(s)   TooltipEP01945471.9  / EP1296652
Fees paidRenewal fee
07.01.2008Renewal fee patent year 03
07.01.2008Renewal fee patent year 04
07.01.2008Renewal fee patent year 05
07.01.2008Renewal fee patent year 06
07.01.2008Renewal fee patent year 07
17.06.2008Renewal fee patent year 08
11.06.2009Renewal fee patent year 09
14.07.2010Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
30.06.201010   M06   Fee paid on   14.07.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US4151274  (SCHLUETER KARL W [DE], et al) [X] 28-32,55,57,58,60-79,94,95,98-102,108-110,115-117,123 * the whole document *;
 [X]US4369784  (DE BUMAN ALAIN [CH], et al) [X] 28-42,61-79,81-89,94,95,98-102,108,123 * the whole document *;
 [X]DE3523454  (NUERNBERG EBERHARD PROF DR [DE], et al) [X] 28-34,55,57,58,60-68,70,73,76-83,108,109,115-117,123 * the whole document *;
 [DX]US4765986  (LIEDTKE RAINER K [DE]) [DX] 1-4,8,12,15,17,21,22,32,34,36,52,53,59,60,104-106,108,112,113,115,118,120,122,123 * column 2, line 17 - line 28 * * column 2, line 45 - line 53 * * column 3, line 8 - line 27 * * column 3, line 42 - line 54 * * column 4, line 37 - line 42 * * column 4, line 61 - column 5, line 2; claims 1,8,9 *;
 [A]US4892890  (DAMANI NALINKANT C [US]) [A] 1-120,122,123 * the whole document *;
 [X]EP0376852  (CIRD [FR]) [X] 1,3,10,17-23,25-32,34-36,42,43,104-113,115,117-123 * page 2, line 28 - page 3, line 20 * * page 3, line 51 - page 4, line 40; examples 1-5,8; claims 1,4-6,9 *;
 [A]US5597849  (MCGINITY JAMES W [US], et al) [A] 1-120,122,123* the whole document *;
 [DX]US5863941  (LIEDTKE RAINER K [DE]) [DX] 1-3,8,13,14,17,21,22,32,34,36,45,48-50,60,104-106,108,110,112,113,115,118,120,122,123 * page 3, line 18 - line 31 * * column 4, line 31 - line 46 * * column 4, line 59 - column 5, line 40 * * column 5, line 49 - line 54 * * column 6, line 4 - line 14 * * column 6, line 28 - line 44 * * column 6, line 51 - line 62; claims 1,2,5,9-11 *
by applicantUS4765986
 WO9119222
 EP0375763
 US5863941
    - Remington's Pharmaceutical Sciences, MERCK PUBLISHING CO., (1985), pages 773 - 791
    - the Cosmetic and Toiletry Fragrance Handbook, THE COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION, INC., (1989), page 56
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.